Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06181734
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2023-11-27
Brief Title:
Ivosidenib TIBSOVO Combined With Azacitidine According to Current SmPC
Sponsor:
iOMEDICO AG
Organization:
iOMEDICO AG
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia AML |
Keywords:
| Name | View |
|---|---|
| IDH1 R132 mutation | View |